Closing Bell: Market Mayhem Continues, Investors Lose Rs 10 Lakh Crore In 4 Days; Sensex & Nifty Fall

The Indian stock markets closed on a grim note today, December 19, with benchmark indices taking a hit. The Sensex tumbled by 964 points, settling at 79,218, while the Nifty declined 247 points to finish at 23,952. Midcap and smallcap indices also faced the heat but displayed relative resilience compared to largecap counterparts, with the BSE Midcap slipping by 0.30% and the BSE Smallcap down by 0.28%.

Investor sentiment was severely impacted, wiping out nearly Rs 3 lakh crore from the market's overall valuation. The market capitalization of BSE-listed firms shrank to Rs 450 lakh crore from Rs 452.6 lakh crore the previous day. The cumulative four-day carnage has erased over Rs 10 lakh crore from the markets.

Sectoral Performance

Most sectors ended the day deep in the red, with indices like Nifty Bank, Financial Services, IT, and Consumer Durables registering over 1% declines. The Nifty Pharma index defied the overall trend, surging almost 2% due to robust buying in major pharma stocks.

Key losers included Bajaj Finserv, Asian Paints, and JSW Steel, while Dr Reddy's Laboratories (DRL) stood out as the top Nifty gainer, rising 4% on a positive brokerage upgrade.

Why the Markets Are Bleeding?

Hawkish US Fed Signals

The US Federal Reserve's decision to cut its benchmark interest rate by 25 basis points to 4.25-4.50% was overshadowed by its revised outlook. The Fed indicated a slower pace of rate cuts in 2025, projecting only two quarter-point reductions instead of the anticipated three or four cuts. This hawkish stance spooked global markets, with major indices like the S&P 500 and Nasdaq losing 3% overnight.

Persistent FII Outflows

Foreign Institutional Investors (FIIs) continued to pull funds from Indian equities, selling over Rs 8,000 crore in the last three sessions. A strengthening US dollar and rising US bond yields exacerbated outflows, weighing heavily on domestic equities.

Rupee at Record Low

The Indian Rupee's plunge to a historic low of 85.3 against the dollar added to the market's woes. A depreciating Rupee reduces the attractiveness of Indian assets to foreign investors, further triggering capital flight.

Macroeconomic Challenges

India's trade deficit surged to a record $37.84 billion in November, significantly higher than the $21.31 billion deficit in November 2023. This ballooning gap, coupled with slowing GDP growth (the lowest in nearly two years), painted a grim macroeconomic picture.

Uncertainty Over Earnings Recovery

The market remains cautious about corporate earnings recovery. While experts expect improved Q4 results, weak performances in Q1 and Q2 have left investors sceptical about immediate gains, dampening near-term sentiment.

Despite the overall market downturn, specific stocks managed to grab investor attention. Dr Reddy's Laboratories (DRL) gained 4% after a brokerage upgrade by Nomura. SpiceJet surged 6% after settling a $16 million dispute with Genesis.

IOL Chemicals jumped 8% as the company announced a stock split consideration. Lupin rose on receiving USFDA approval for an HIV and Hepatitis B drug. MobiKwik doubled its IPO price within two days of listing, ending 5% higher today.

Sugar Stocks gained traction as Union Minister Nitin Gadkari announced measures to aid exports and increase the Minimum Support Price (MSP). Asian Paints dropped to a four-year low following the exit of two top executives. Stove Kraft gained 4% on becoming a supply partner for IKEA.

The advance-decline ratio skewed slightly towards declines at 1:1, reflecting the bearish undertone. While domestic institutional investors (DIIs) provided some support, their buying was insufficient to offset the aggressive FII selling.

The broader market's trajectory hinges on global cues, particularly developments in the US economy and Federal Reserve policies. Domestic investors will also closely watch the Rupee's movement, corporate earnings in Q3, and macroeconomic indicators such as inflation and GDP growth.